Lonza snaps up Novartis fill-and-finish facility to expand offering

Reuters

Published Jul 01, 2019 06:43

Lonza snaps up Novartis fill-and-finish facility to expand offering

ZURICH (Reuters) - Lonza Group (S:LONN) is buying a sterile fill-and-finish facility from Novartis (S:NOVN) as the Swiss drug ingredients maker boosts its offering for pharmaceuticals companies.